The Patent Finder

Trovagene, Inc.

Also on record
Records under this name other than patents Trovagene, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Trovagene, Inc.

PatentTitleStatus Expires Confidence
US 8,501,924Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,909,118Compositions, Methods and Kits for Isolating Nucleic Acids from Body Fluids Using Anion Exchange Media
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,222,370Nucleophosmin Protein (NPM) Mutants, Corresponding Gene Sequences and Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,163,229Compositions, methods and kits for isolating nucleic acids from body fluids using anion exchange media
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,725,767Nucleophosmin Protein (NPM) Mutants, Corresponding Gene Sequences and Uses Thereof
Formerly held
Term ended
Term ended Oct 28, 2025 · High confidence
Term endedTerm ended Oct 28, 2025High confidence
US 10,155,989Nucleophosmin Protein (NPM) Mutants, Corresponding Gene Sequences and Uses Thereof
Formerly held
Term ended
Term ended Oct 28, 2025 · High confidence
Term endedTerm ended Oct 28, 2025High confidence
US 10,487,366Nucleophosmin Protein (NPM) Mutants, Corresponding Gene Sequences and Uses Thereof
Formerly held
Term ended
Term ended Oct 28, 2025 · High confidence
Term endedTerm ended Oct 28, 2025High confidence
US 7,803,929Kits for diagnosis and monitoring of pathogenic infection by analysis of cell-free pathogenic nucleic acids in urine
Lapsed on the fee record
Ended Sep 28, 2022 · From the USPTO record
Lapsed on the fee recordEnded Sep 28, 2022From the USPTO record
US 8,642,261Genetic Marker for Detection of Human Papillomavirus
Formerly held
Lapsed on the fee record
Ended Feb 4, 2022 · High confidence
Lapsed on the fee recordEnded Feb 4, 2022High confidence
US 9,816,148Amplification and Sequencing of Transrenal Nucleic Acids
Formerly held
Lapsed on the fee record
Ended Nov 14, 2021 · Medium confidence
Lapsed on the fee recordEnded Nov 14, 2021Medium confidence
10 of 20 patents shown.
Pro members see all 20.
Pro members: see all 20 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited